ALZN

Alzamend Neuro, Inc. Common Stock

2.39

USD

ALZN Earnings Reports

Positive Surprise Ratio

ALZN beat 8 of 16 last estimates.

50%

Next Report

Date of Next Report

Mar 09, 2026

Estimate for Q3 26 (Revenue/ EPS)

-$2.10

Implied change from Q2 26 (Revenue/ EPS)

+600.00%

Implied change from Q3 25 (Revenue/ EPS)

+22.81%

Alzamend Neuro, Inc. Common Stock earnings per share and revenue

On Dec 09, 2025, ALZN reported earnings of -0.30 USD per share (EPS) for Q2 26, beating the estimate of -1.99 USD, resulting in a 84.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.46% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 4 analysts forecast an EPS of -2.10 USD, with revenue projected to reach -- USD, implying an increase of 600.00% EPS, and increase of 0.00% in Revenue from the last quarter.

FAQ

What were Alzamend Neuro, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Alzamend Neuro, Inc. Common Stock reported EPS of -$0.30, beating estimates by 84.96%, and revenue of $0.00, 0% as expectations.

How did the market react to Alzamend Neuro, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -0.46%, changed from $2.17 before the earnings release to $2.16 the day after.

When is Alzamend Neuro, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 09, 2026.

What are the forecasts for Alzamend Neuro, Inc. Common Stock's next earnings report?

Based on 4 analysts, Alzamend Neuro, Inc. Common Stock is expected to report EPS of -$2.10 and revenue of -- for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.